Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CO2 Management of MAPCA Flow in Cyanotic Children
NCT02358382Unknown
- Sponsor
- Great Ormond Street Hospital
- Start
- Mar 2016
- Primary completion
- Jul 2017
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Randomised, open-label trial of Carbon dioxide in congenital heart defect (CHD), sponsored by Great Ormond Street Hospital. Primary endpoint: Major Aortopulmonary Collateral Artery Flow. Status: unknown.
02
Drugs
Carbon dioxide
03
Conditions
congenital heart defect (CHD)
Beyond the preview
Go deeper on NCT02358382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02358382.